Invention Grant
- Patent Title: Crystalline forms of a selective c-kit kinase inhibitor
-
Application No.: US17305862Application Date: 2021-07-15
-
Publication No.: US11767319B2Publication Date: 2023-09-26
- Inventor: Gregg F. Keaney , Leonard Walter Rozamus, Jr. , Jonathan James Loughrey , Jaclyn Raeburn , Yuxiang Song
- Applicant: Third Harmonic Bio, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Third Harmonic Bio, Inc.
- Current Assignee: Third Harmonic Bio, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Chad E. Davis
- Priority: WO TCN2020102095 2020.07.15
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
The present disclosure relates generally to various forms and compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
Public/Granted literature
- US20220056026A1 CRYSTALLINE FORMS OF A SELECTIVE C-KIT KINASE INHIBITOR Public/Granted day:2022-02-24
Information query
